PROF: Profound Medical Corp Company Profile & Statistics

About

Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada.

Info & Links

CEO

Arun Menawat

Headquarters

2400 SKYMARK AVENUE, UNIT 6
MISSISSAUGA, A6 L4W 5K5, CANADA

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

131

Profound Medical Corp Statistics

Valuation Measures

Market Capitalization²

182.48M

Enterprise Value

160.96M

Enterprise Value/EBITDA(ttm)

-5.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

24.73

Price to Book(mrq)

5.87

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

61.83%

Operating Margin(ttm)

-349.41%

Profit Margin(ttm)

-352.13%

Return on Equity(ttm)

-85.22%

Return on Invested Capital(ttm)

-81.34%

Return on Assets(ttm)

-64.87%

Income Statement

Revenue(ttm)

8.98M

Revenue Per Share(ttm)

Gross Profit(ttm)

5.57M

EBITDA(ttm)³

-31.93M

Net Income Available to Common(ttm)

-31.39M

Diluted EPS(ttm)

-1.34

Share Statistics

Beta (5Y Monthly)

0.88

52-Week Change

-30.39%

S&P 500 52-Week Change

27.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

29.57M

% Held by Insiders

1.52%

% Held by Institutions

47.86%

Balance Sheet

Total Cash(mrq)

27.12M

Total Cash Per Share(mrq)

Total Debt(mrq)

5.60M

Total Debt/Equity(mrq)

18.02%

Current Ratio(mrq)

6.12%

Quick Ratio(mrq)

5.16%

Book Value Per Share(mrq)

1.26

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-17.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PROF

Profound Medical Corp

Profound Medical Corp Profile